Correlation Between SAB Biotherapeutics and Acurx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Acurx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Acurx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Acurx Pharmaceuticals LLC, you can compare the effects of market volatilities on SAB Biotherapeutics and Acurx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Acurx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Acurx Pharmaceuticals.

Diversification Opportunities for SAB Biotherapeutics and Acurx Pharmaceuticals

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between SAB and Acurx is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Acurx Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acurx Pharmaceuticals LLC and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Acurx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acurx Pharmaceuticals LLC has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Acurx Pharmaceuticals go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Acurx Pharmaceuticals

Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 17.5 times more return on investment than Acurx Pharmaceuticals. However, SAB Biotherapeutics is 17.5 times more volatile than Acurx Pharmaceuticals LLC. It trades about 0.11 of its potential returns per unit of risk. Acurx Pharmaceuticals LLC is currently generating about -0.01 per unit of risk. If you would invest  7.00  in SAB Biotherapeutics on September 3, 2024 and sell it today you would lose (0.25) from holding SAB Biotherapeutics or give up 3.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy75.15%
ValuesDaily Returns

SAB Biotherapeutics  vs.  Acurx Pharmaceuticals LLC

 Performance 
       Timeline  
SAB Biotherapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Acurx Pharmaceuticals LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acurx Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

SAB Biotherapeutics and Acurx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SAB Biotherapeutics and Acurx Pharmaceuticals

The main advantage of trading using opposite SAB Biotherapeutics and Acurx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Acurx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will offset losses from the drop in Acurx Pharmaceuticals' long position.
The idea behind SAB Biotherapeutics and Acurx Pharmaceuticals LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing